Author details
Author Cheradame H |
Available item(s) by this author (8)
sorted by (Issue date descending, Issue date descending, System of projection of the document ascending) | Add the result to the basket | Make a suggestion | Refine your search
Article
Billiet L, Author ; Gomez JP ; Berchel M ; Jaffrès PA ; Le Gall T ; Montier T ; Bertrand E ; Cheradame H ; Guegan P ; Mével M ; Pitard B ; Benvegnu T ; Lehn P ; Pichon C ; Midoux P | 2012Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Billiet L ; Gonçalves C ; Berchel M ; Jaffrès PA ; Montier T ; Lehn P ; Bertrand E ; El-Ghoul Y ; Cheradame H ; Guegan P ; Pichon C ; Midoux P | 2011Duchenne muscular dystrophy (DMD) is one of the most severe myopathies caused by mutations in the dystrophin gene. Gene therapy is being investigated to introduce by non viral vectors, the normal dystrophin gene into skeletal muscle cells. The k[...]Article
Article
Brissault B ; Kirchler A ; Leborgne C ; Jarroux N ; Cheradame H ; Guis C | 2007Accès au résumé PubMed / to PubMed abstractArticle
Brissault B ; Kichler A ; Leborgne C ; Danos O ; Cheradame H ; Gau J ; Auvray L ; Guis C | 2006Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Brissault B ; Kichler A ; Cheradame H ; Leborgne C ; Guis C | 2005Communication n° 656 Introduction : Pluronics (Poly(ethylene oxide-b-propylene oxide-b-ethylene oxide) PEO-PPO-PEO) were used in vivo for gene delivery to muscles and appeared to be valuable for this application. In solution, owing to their amph[...]